7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide
|
|
|
- CAS-Nr.
- 942195-86-0
- Englisch Name:
- 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide
- Synonyma:
- 4-hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide;Tegoprazan Impurity 19;Intermediate of Tegolasheng;Tigola produced Impurity 19;N-Ts Tegoprazan parent nucleus;4-Hydroxy-N,N,2-trimethyl-1-tosylbenzimidazole-6-carboxamide;7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide;4-hydroxy-N,N, 2-trimethyl-1-p-toluenesulfonyl-1H-benzo [d] imidazole-6-formamide;4-hydroxy-N N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-1H-benzimidazole-6-carboxamide;1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-
- CBNumber:
- CB72610066
- Summenformel:
- C18H19N3O4S
- Molgewicht:
- 373.43
- MOL-Datei:
- 942195-86-0.mol
|
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Eigenschaften
- Siedepunkt:
- 654.0±65.0 °C(Predicted)
- Dichte
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C, sealed storage, away from moisture
- pka
- 7.07±0.40(Predicted)
- Aussehen
- White to off-white Solid
- InChI
- InChI=1S/C18H19N3O4S/c1-11-5-7-14(8-6-11)26(24,25)21-12(2)19-17-15(21)9-13(10-16(17)22)18(23)20(3)4/h5-10,22H,1-4H3
- InChIKey
- AGWVNJPTTKMUQO-UHFFFAOYSA-N
- SMILES
- C1(C)N(S(C2=CC=C(C)C=C2)(=O)=O)C2=CC(C(N(C)C)=O)=CC(O)=C2N=1
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide is mainly used in organic synthesis or pharmaceutical backbone materials. It can be used in the synthesis of benzimidazole derivatives as selective acid pump inhibitors for the treatment of conditions with antagonistic activity mediated by the acid pump, such as gastrointestinal disorders, gastro-oesophageal disorders, gastro-oesophageal reflux disease (GERD), laryngo-pharyngeal reflux disease, peptic ulcers, gastric ulcers, duodenal ulcers, and others.
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 76)Lieferanten
- 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide
- 4-hydroxy-N N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-1H-benzimidazole-6-carboxamide
- 1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-
- Tegoprazan Impurity 19
- 4-hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
- 4-Hydroxy-N,N,2-trimethyl-1-tosylbenzimidazole-6-carboxamide
- 4-hydroxy-N,N, 2-trimethyl-1-p-toluenesulfonyl-1H-benzo [d] imidazole-6-formamide
- N-Ts Tegoprazan parent nucleus
- Tigola produced Impurity 19
- 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide (Tegoprazan)
- Intermediate of Tegolasheng
- 942195-86-0
